(Q35525678)

English

Heparin and warfarin anticoagulation intensity as predictors of recurrence after deep vein thrombosis or pulmonary embolism: a population-based cohort study

scientific article published on 2 September 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

8 August 2017

Heparin and warfarin anticoagulation intensity as predictors of recurrence after deep vein thrombosis or pulmonary embolism: a population-based cohort study (English)

1 reference

Europe PubMed Central

8 August 2017

1 reference

based on heuristic

inferred from title

anticoagulation

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

deep vein thrombosis

1 reference

based on heuristic

inferred from title

L. Joseph Melton

6

object named as

L Joseph Melton

1 reference

Europe PubMed Central

8 August 2017

author name string

John A Heit

1

1 reference

Europe PubMed Central

8 August 2017

Brian D Lahr

2

1 reference

Europe PubMed Central

8 August 2017

Tanya M Petterson

3

1 reference

Europe PubMed Central

8 August 2017

Kent R Bailey

4

1 reference

Europe PubMed Central

8 August 2017

Aneel A Ashrani

5

1 reference

Europe PubMed Central

8 August 2017

language of work or name

0 references

publication date

2 September 2011

1 reference

Europe PubMed Central

8 August 2017

1 reference

Europe PubMed Central

8 August 2017

118

1 reference

Europe PubMed Central

8 August 2017

18

1 reference

Europe PubMed Central

8 August 2017

4992-4999

1 reference

Europe PubMed Central

8 August 2017

Is diabetes mellitus an independent risk factor for venous thromboembolism?: a population-based case-control study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3208304

12 July 2018

Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3208304

12 July 2018

Treatment and prevention of heparin-induced thrombocytopenia: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3208304

12 July 2018

Parenteral anticoagulants: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3208304

12 July 2018

Comparison of fixed-dose weight-adjusted unfractionated heparin and low-molecular-weight heparin for acute treatment of venous thromboembolism

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3208304

12 July 2018

Venous thromboembolism: disease burden, outcomes and risk factors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3208304

12 July 2018

Antithrombotic therapy practices in US hospitals in an era of practice guidelines

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3208304

12 July 2018

Poor anticoagulation quality in the first 3 months after unprovoked venous thromboembolism is a risk factor for long-term recurrence.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3208304

12 July 2018

Anticoagulant drugs in the treatment of pulmonary embolism. A controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3208304

12 July 2018

Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3208304

12 July 2018

Long-term, low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3208304

12 July 2018

A population-based study of the effectiveness of inferior vena cava filter use among patients with venous thromboembolism.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3208304

12 July 2018

Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3208304

12 July 2018

Predictors of recurrence after deep vein thrombosis and pulmonary embolism: a population-based cohort study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3208304

12 July 2018

A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3208304

12 July 2018

College of American Pathologists Conference XXXI on laboratory monitoring of anticoagulant therapy: laboratory monitoring of unfractionated heparin therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3208304

12 July 2018

Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3208304

12 July 2018

Apparent heparin resistance form elevated factor VIII in a patient with postoperative deep venous thrombosis. A case report

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3208304

12 July 2018

The relation between the activated partial thromboplastin time response and recurrence in patients with venous thrombosis treated with continuous intravenous heparin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3208304

12 July 2018

History of the Rochester Epidemiology Project

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3208304

12 July 2018

A method to determine the optimal intensity of oral anticoagulant therapy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3208304

12 July 2018

Mechanism of the anticoagulant effect of warfarin as evaluated in rabbits by selective depression of individual procoagulant vitamin K-dependent clotting factors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3208304

12 July 2018

The weight-based heparin dosing nomogram compared with a "standard care" nomogram. A randomized controlled trial.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3208304

12 July 2018

Different intensities of oral anticoagulant therapy in the treatment of proximal-vein thrombosis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3208304

12 July 2018

Kaolin partial thromboplastin time: high levels of procoagulants producing short clotting times or masking deficiencies of other procoagulants or low concentrations of anticoagulants

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3208304

12 July 2018

A prospective study of the value of monitoring heparin treatment with the activated partial thromboplastin time

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3208304

12 July 2018

Continuous intravenous heparin compared with intermittent subcutaneous heparin in the initial treatment of proximal-vein thrombosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3208304

12 July 2018

Acenocoumarol and heparin compared with acenocoumarol alone in the initial treatment of proximal-vein thrombosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3208304

12 July 2018

Relationship between the anticoagulant and antithrombotic effects of heparin in experimental venous thrombosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3208304

12 July 2018

Interlaboratory agreement in the monitoring of unfractionated heparin using the anti-factor Xa-correlated activated partial thromboplastin time.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3208304

26 September 2018

Treatment of venous thromboembolism: adherence to guidelines and impact of physician knowledge, attitudes, and beliefs

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3208304

26 September 2018

High plasma levels of factor VIII and risk of recurrence of venous thromboembolism.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3208304

26 September 2018

Comparison of low-intensity warfarin therapy with conventional-intensity warfarin therapy for long-term prevention of recurrent venous thromboembolism

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3208304

26 September 2018

Recurrent venous thrombosis and heparin therapy: an evaluation of the importance of early activated partial thromboplastin times.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3208304

26 September 2018

Length of hospital stay for treatment of deep venous thrombosis and the incidence of recurrent thromboembolism.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3208304

26 September 2018

Studies in intravascular coagulation. IV. The effect of heparin and dicumarol on serum-induced venous thrombosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/21890644

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical risk factors and timing of recurrent venous thromboembolism during the initial 3 months of anticoagulant therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/21890644

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Optimal Therapeutic Level of Heparin Therapy in Patients With Venous Thrombosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/21890644

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A lower risk of recurrent venous thrombosis in women compared with men is explained by sex-specific risk factors at time of first venous thrombosis in thrombophilic families

1 reference

https://pubmed.ncbi.nlm.nih.gov/21890644

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Safety and efficacy of warfarin started early after submassive venous thrombosis or pulmonary embolism

1 reference

https://pubmed.ncbi.nlm.nih.gov/21890644

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Control of heparin therapy. Sensitivity of the activated partial thromboplastin time for monitoring the antithrombotic effects of heparin

1 reference

https://pubmed.ncbi.nlm.nih.gov/21890644

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Relation between the time to achieve the lower limit of the APTT therapeutic range and recurrent venous thromboembolism during heparin treatment for deep vein thrombosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/21890644

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Guidelines on the use and monitoring of heparin

1 reference

https://pubmed.ncbi.nlm.nih.gov/21890644

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Monitoring unfractionated heparin with the aPTT: time for a fresh look

1 reference

https://pubmed.ncbi.nlm.nih.gov/21890644

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Heparin for 5 days as compared with 10 days in the initial treatment of proximal venous thrombosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/21890644

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Warfarin. From bedside to bench

1 reference

https://pubmed.ncbi.nlm.nih.gov/21890644

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1182/BLOOD-2011-05-357343

1 reference

Europe PubMed Central

8 August 2017

1 reference

Europe PubMed Central

8 August 2017

1 reference

Europe PubMed Central

8 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35525678&oldid=1662176879"